An unwanted reaction by the use of Haloperidol in hyperkinetic delirium

Aging Clin Exp Res. 2021 May;33(5):1409-1411. doi: 10.1007/s40520-020-01649-2. Epub 2020 Jul 15.

Authors

Francesca Remelli^{1

2}, Maura Bugada^{1

2}, Giulia Matteucci^{1

2}, Mattia Brunori², Giordano Gianotti², Amedeo Zurlo^{1

2}, Stefano Volpato^{3

4}

Affiliations

¹ Department of Medical Sciences, University of Ferrara, Via Aldo Moro 8, 44121, Ferrara, Italy.
² Geriatrics Unit, Azienda Ospedaliero-Universitaria di Ferrara, Via Aldo Moro 8, 44121, Ferrara, Italy.
³ Department of Medical Sciences, University of Ferrara, Via Aldo Moro 8, 44121, Ferrara, Italy. vlt@unife.it.
⁴ Orthogeriatrics Unit, Azienda Ospedaliero-Universitaria di Ferrara, Via Aldo Moro 8, 44121, Ferrara, Italy. vlt@unife.it.

No abstract available

Keywords: Elderly; Haloperidol; Hyperkinetic delirium; Myoclonus; Pancytopenia.

MeSH terms

Antipsychotic Agents* / adverse effects
Delirium* / chemically induced
Delirium* / drug therapy
Haloperidol / adverse effects
Humans

Substances

Antipsychotic Agents
Haloperidol